Advisor Group Holdings, Inc. Vigil Neuroscience, Inc. Put Options Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding VIGL
# of Institutions
52Shares Held
29.3MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$14.5 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$10.5 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$9.99 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$4.9 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$4.33 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $70.4M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...